These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22309224)

  • 1. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
    Rüb U; Bürk K; Timmann D; den Dunnen W; Seidel K; Farrag K; Brunt E; Heinsen H; Egensperger R; Bornemann A; Schwarzacher S; Korf HW; Schöls L; Bohl J; Deller T
    Neuropathol Appl Neurobiol; 2012 Dec; 38(7):665-80. PubMed ID: 22309224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinocerebellar ataxia type 6 (SCA6): neurodegeneration goes beyond the known brain predilection sites.
    Gierga K; Schelhaas HJ; Brunt ER; Seidel K; Scherzed W; Egensperger R; de Vos RA; den Dunnen W; Ippel PF; Petrasch-Parwez E; Deller T; Schöls L; Rüb U
    Neuropathol Appl Neurobiol; 2009 Oct; 35(5):515-27. PubMed ID: 19207264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7.
    Rüb U; Brunt ER; Petrasch-Parwez E; Schöls L; Theegarten D; Auburger G; Seidel K; Schultz C; Gierga K; Paulson H; van Broeckhoven C; Deller T; de Vos RA
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):635-49. PubMed ID: 17083478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7).
    Hoche F; Seidel K; Brunt ER; Auburger G; Schöls L; Bürk K; de Vos RA; den Dunnen W; Bechmann I; Egensperger R; Van Broeckhoven C; Gierga K; Deller T; Rüb U
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):479-91. PubMed ID: 18221259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments.
    Rüb U; Brunt ER; Seidel K; Gierga K; Mooy CM; Kettner M; Van Broeckhoven C; Bechmann I; La Spada AR; Schöls L; den Dunnen W; de Vos RA; Deller T
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):155-68. PubMed ID: 17971076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2).
    Rüb U; Farrag K; Seidel K; Brunt ER; Heinsen H; Bürk K; Melegh B; von Gall C; Auburger G; Bohl J; Korf HW; Hoche F; den Dunnen W
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):634-43. PubMed ID: 23363055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinocerebellar ataxia type 4 (SCA4): Initial pathoanatomical study reveals widespread cerebellar and brainstem degeneration.
    Hellenbroich Y; Gierga K; Reusche E; Schwinger E; Deller T; de Vos RA; Zühlke C; Rüb U
    J Neural Transm (Vienna); 2006 Jul; 113(7):829-43. PubMed ID: 16362839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.
    Rüb U; Schöls L; Paulson H; Auburger G; Kermer P; Jen JC; Seidel K; Korf HW; Deller T
    Prog Neurobiol; 2013 May; 104():38-66. PubMed ID: 23438480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
    Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
    Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
    Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study.
    Alcauter S; Barrios FA; Díaz R; Fernández-Ruiz J
    Neuroimage; 2011 Mar; 55(1):1-7. PubMed ID: 21147232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2).
    Gierga K; Bürk K; Bauer M; Orozco Diaz G; Auburger G; Schultz C; Vuksic M; Schöls L; de Vos RA; Braak H; Deller T; Rüb U
    Acta Neuropathol; 2005 Jun; 109(6):617-31. PubMed ID: 15906049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinocerebellar ataxia type 2 (SCA2): identification of early brain degeneration in one monozygous twin in the initial disease stage.
    Hoche F; Balikó L; den Dunnen W; Steinecker K; Bartos L; Sáfrány E; Auburger G; Deller T; Korf HW; Klockgether T; Rüb U; Melegh B
    Cerebellum; 2011 Jun; 10(2):245-53. PubMed ID: 21128038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance.
    Rüb U; Del Turco D; Del Tredici K; de Vos RA; Brunt ER; Reifenberger G; Seifried C; Schultz C; Auburger G; Braak H
    Brain; 2003 Oct; 126(Pt 10):2257-72. PubMed ID: 12847080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).
    Rüb U; Brunt ER; Deller T
    Curr Opin Neurol; 2008 Apr; 21(2):111-6. PubMed ID: 18317266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.